The African Union Centre for Ticks and Tick-Borne Diseases (CTTBD) was established by the African Union as a self-financing Trust to assist with the management of ticks and tick-borne diseases in the region. It is located in Lilongwe, Malawi, where its assets include office space, various animal facilities, laboratories and a vaccine production plant.In addition to vaccine production, CTTBD offers a range of complementary services and products including training in epidemiology and control techniques for tick-borne diseases(TBDs), production of quality assured vaccines, back up services to vaccines against TBDs, assistance in the investigation and control of tick-borne diseasesInitially, the Centre was called the Vaccine Production Centre (VPC) from 1994 but was renamed the Centre for Ticks and Tick-borne Diseases (CTTBD) in 2000. The facility has been in operation for more than 30 years, manufacturing and selling animal vaccines. CTTBD has unique resources and improved internal management, accounting and administration resources, including stock and accounting control systems


To be the leading Centre of excellence in Africa for the Production of animal vaccines, and the control of Ticks and Tick-Borne Diseases



CTTBD exists to consistently provide demand driven services to the African Continent through a well-trained, motivated, friendly and dedicated workforce, with the view of building stakeholders’value



With the support of the Board, the Centre has over the years responded to diversify its activities to cover not only tick-related diseases but also other animal disease vectors and vector-borne diseases like Tsetseand Trypanosomosis respectively, and short to medium term training as well as collaborative research with other institutions and companies

CTTBD has been supporting farmers in the region inECF vaccination inorder to minimize cattle losses due to ECF. Occasionally supply has been made,for use in scientific work,tooth er research institutions in Europe.Within Africa,the vaccine has been supplied toTanzania, Zambia,Uganda,Kenya and Malawi.Research and discussions have also been held on the possibility of producing and supplying the vaccine to Rwanda in the near future.The CTTBD also produces diagnostic reagents for some tick-borne diseases. These diagnostic reagents (in the form of antigen coated slides) are used by other laboratories in the region as standards against which confirmatory diagnosis of tick-borne diseases infections caused by Theileria parva